TAIGEN BIOPHARMACEUTICALS HLDGS LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 4157 for the last quarter is 8.59 M TWD, and it's 7.72% lower compared to the previous quarter. The net income of Q4 23 is 185.67 M TWD.